Learning Objectives:

1.Understand the potential targets of small molecule therapy in patients with IBD;
2.Understand the relative efficacy of different small molecule therapies;
3.To discuss a best practice approach to small molecule therapy in children and adolescents with IBD.
Session date: 
02/11/2026 - 12:00pm to 1:00pm EST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
    Children’s National Hospital designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Participation
    Successful completion of this continuing education activity.
Please login or register to take this course.
Faculty List: 
Speaker(s)

Carmelo Cuffari, MD, FRCP(C), FACG

has no relevant financial relationships to disclose at this time.